Inserm is paying close attention to the level 2 incident, declared on 21 October 2015 by the French Nuclear Safety Authority (ASN), which occurred in a joint Inserm/University of Bordeaux laboratory.
Inserm notes that the University will implement measures requested by ASN for which it is responsible as the owner of the premises. Inserm will give the University its complete support.
For Inserm’s part, two staff members who were exposed have been examined by the preventive medicine service. Following medical tests, the individuals in question have been allowed return to work, and will be monitored regularly.
Le Paris Saclay Cancer Cluster est désormais organisé sous la forme d’une association, dont l’objet et les ambitions ont été présentés ce jour dans les locaux de Gustave Roussy, en présence d’Olivier Véran, Ministre des Solidarités et de la Santé, de Frédérique ...